News

Visit from Beckman Coulter Diagnostics focused on market development

Jun 11, 2026

We had the pleasure of welcoming our long-term partner Beckman Coulter Diagnostics this week for valuable discussions on the continued sales and market development for our IRMA and ELISA portfolio. Their strong market presence and ability to effectively navigate a dynamic landscape remain truly impressive, and we look forward to continuing to develop our collaboration.

Healthcare day 2026

On April 14, IDL participated at Redeye Healthcare Day. CEO Anders Hultman presented the company and shared more about its strategy, current and future markets, and our joint venture with concile. Watch the presentation here

read more

CACLP and meeting with new distributor

During CACLP in Xiamen, China’s largest IVD exhibition, IDL Diagnostics had the opportunity to meet a wide range of industry players, exchange valuable insights, and further explore the fast-evolving Chinese IVD market. The trip concluded in Tianjin with our first...

read more